STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Viatris Inc Ord Shs Stock Price, News & Analysis

VTRS Nasdaq

Welcome to our dedicated page for Viatris Ord Shs news (Ticker: VTRS), a resource for investors and traders seeking the latest updates and insights on Viatris Ord Shs stock.

Viatris Inc. (NASDAQ: VTRS) is a global healthcare leader formed through the merger of Upjohn and Mylan, delivering essential medicines across 165+ countries. This page provides centralized access to official corporate announcements and market-moving developments.

Investors and analysts will find timely updates including earnings reports, regulatory milestones, and strategic partnerships. Track the company’s progress in generic pharmaceuticals, biosimilars, and therapeutic innovations through verified press releases.

Our curated news feed serves as a reliable resource for understanding Viatris’ operational decisions, product pipeline advancements, and global healthcare initiatives. Bookmark this page to stay informed about one of the pharmaceutical industry’s most diversified companies.

Rhea-AI Summary

Viatris has released its 2023 Sustainability Report, highlighting extensive efforts in India to address critical health and social needs. Key initiatives include:

  • Supporting Akshaya Vidya, a supplementary education program for underprivileged children.
  • Developing a watershed in Ranga Reddy District to boost groundwater and agricultural productivity.
  • Partnering with Sportz Village Foundation to promote fitness among children in Hyderabad.

In cancer care, Viatris, in collaboration with Tata Memorial Center, has screened over 8 million people for oral cancer, expanding from six districts to all 34 in Maharashtra and to six other states. The Healthy Liver Healthy Delhi program has provided over 30,000 liver health screenings since 2017. Viatris also supports sustainable farming practices and is working to address tuberculosis (TB) through multiple community programs, benefiting over 80,000 people in 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.95%
Tags
none
-
Rhea-AI Summary

Viatris, a global healthcare company, has released its 2023 Sustainability Report highlighting efforts to reduce packaging materials. Key initiatives include:

  • Reducing paper use by 90 metric tons at oral-solid dose manufacturing sites
  • Cutting 2 metric tons of plastic and 5 metric tons of wood through bulk packaging optimization
  • Replacing 88 metric tons of plastic with polythene bags
  • Reducing plastic use by 18 metric tons through shrink bundle film optimization

The company is also exploring e-labeling, implementing PCTFE mitigation in blister packaging, and pursuing carton-less initiatives. Viatris is working on harmonizing packaging across markets, including the use of quadrilingual packs to reduce the need for individual language-specific bottles. In Cairo, Egypt, the facility has started reusing empty supply carton boxes, saving four tons annually.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.7%
Tags
none
-
Rhea-AI Summary

Viatris Inc. (NASDAQ: VTRS) announced positive top-line results from its Phase 3 study of EFFEXOR® (venlafaxine) in Japanese adults with Generalized Anxiety Disorder (GAD). The study met its primary objective, demonstrating superiority of EFFEXOR® over placebo in anxiolytic effects at 8 weeks. All seven secondary efficacy endpoints were also met.

EFFEXOR® was generally well tolerated, with low discontinuation rates due to adverse events and no serious adverse events observed. The company plans to submit to the Pharmaceuticals and Medical Devices Agency (PMDA) in 2025. This study is significant as there are currently no approved treatments for GAD in Japan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
Rhea-AI Summary

Viatris Inc. (NASDAQ:VTRS), a global healthcare company, has been named to Forbes' list of World's Best Employers 2024 for the fourth consecutive year. This recognition, presented by Forbes and Statista, is based on an independent survey of over 300,000 participants across 50 countries.

Andrew Enrietti, Chief People Officer at Viatris, attributed this achievement to the company's strong culture that prioritizes employee well-being, inclusivity, diversity, growth opportunities, and work-life balance. The selection process involved participants rating their willingness to recommend their employer and reviewing various aspects of employment.

This recognition follows Viatris' inclusion in other prestigious lists such as TIME's World's Most Sustainable Companies 2024, USA Today's America's Climate Leaders 2024, and 3BL's 100 Best Corporate Citizens of 2023. The company has also received Great Place to Work® certifications and Top Employers certifications in multiple countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
none
-
Rhea-AI Summary

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, has been named to Forbes' list of World's Best Employers 2024 for the fourth consecutive year. This recognition, presented by Forbes and Statista, is based on an independent survey of over 300,000 participants across 50 countries.

Andrew Enrietti, Chief People Officer at Viatris, attributed this achievement to the company's focus on its people and strong culture, which prioritizes well-being, inclusivity, diversity, growth opportunities, and work-life balance. The survey assessed employees' willingness to recommend their employer and their reviews of various employment aspects.

This accolade follows Viatris' inclusion in other prestigious lists such as TIME's World's Most Sustainable Companies 2024, USA Today's America's Climate Leaders 2024, and 3BL's 100 Best Corporate Citizens of 2023. The company has also received Great Place to Work® and Top Employers certifications in multiple countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
none
-
Rhea-AI Summary

Viatris has released its 2023 Sustainability Report, highlighting expanded contractor training initiatives. The company is constructing a new injectable manufacturing facility in Krishnagiri, India, emphasizing safety as a top priority. The project has achieved 2.3 million incident-free man hours and is expected to be completed by early 2025.

Key safety initiatives implemented at the 69,000 square meter site include:

  • Establishing a Safety Park for equipment overview
  • Providing nearly 8,000 manhours of EHS trainings
  • Deploying a "Permit to Work" program with approximately 23,000 permits issued
  • Implementing a reward program for exemplary safety performance

Jayesh Thakor, Senior Director - EHS Injectable India at Viatris, expressed pride in the project's safety record and thanked the EHS team, contractors, and project team for their support in achieving safety goals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
none
Rhea-AI Summary

Viatris' facility in Komárom, Hungary, has joined the Bird-Friendly Workplace Program in partnership with the Hungarian Ornithological Society. The site, located near the Danube River, encompasses about 4 hectares of diverse habitat for birds and insects. In February 2024, the team installed 50 bird houses and established a breeding wall, expecting to attract about 40 different bird species.

The initiative was proposed by Róbert Klinga, a Quality Control Support Manager and bird enthusiast. The project aims to enhance biodiversity and raise awareness about environmental conservation. As part of the program, Viatris organized a Bird-Friendly Family Day for employees, featuring activities like bird ringing and burrow checks. This effort aligns with Viatris' commitment to sustainability and reducing environmental impact in its operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Viatris' 2023 Sustainability Report highlights the company's commitment to workplace health and safety. With a global workforce across various settings, Viatris implements a comprehensive Environmental, Health and Safety (EHS) Management system. Key focus areas in 2023 included enhancing safety culture, process safety, and equipment safety.

Notable achievements include:

  • A total recordable incident rate of 0.50, significantly lower than the industry average of 1.6
  • Completion of 11 safety climate assessments
  • Over 690 safety walks conducted by leadership teams
  • Expansion of the VSafety Situational Awareness program
  • Enhancement of the Process Safety Global Program
  • Conducting approximately 1,840 risk assessments
  • Implementation of a world-class Process Safety management assessment program in Indore, India
  • Development of an enhanced incident reporting system for non-operations colleagues

These initiatives demonstrate Viatris' ongoing commitment to fostering a culture of health and safety across its global operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Viatris Inc. (NASDAQ: VTRS) announced the pricing terms for its subsidiary Utah Acquisition Sub Inc.'s cash tender offer for up to $575,003,000 of its outstanding 3.950% Senior Notes due 2026. As of the Early Tender Date, $1,449,950,000 aggregate principal amount of notes had been validly tendered. The Total Consideration for notes tendered by the Early Tender Date is $995.64 per $1,000 principal amount, which includes a $30 Early Tender Payment.

Due to oversubscription, Viatris expects to accept tendered notes on a pro rata basis. The Maximum Tender Early Settlement Date is anticipated to be September 20, 2024. The offer expires on October 2, 2024, unless extended or terminated earlier. Viatris also announced the satisfaction and discharge of its 1.650% Senior Notes due 2025 and Mylan Inc.'s redemption of its 2.125% Senior Notes due 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
none
Rhea-AI Summary

Viatris Inc. (NASDAQ: VTRS) announced the early tender results of its subsidiary Utah Acquisition Sub Inc.'s (UAS) cash tender offer for its 3.950% Senior Notes due 2026. UAS has increased the maximum aggregate principal amount from $450,000,000 to $575,003,000. As of the Early Tender Date, $1,449,950,000 in aggregate principal amount was tendered. Due to oversubscription, UAS will accept tenders on a pro rata basis with a proration factor of 39.7%. The Early Tender Payment is $30 per $1,000 principal amount. The Maximum Tender Early Settlement Date is expected to be September 20, 2024. The offer expires on October 2, 2024, unless extended or terminated earlier.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
none

FAQ

What is the current stock price of Viatris Ord Shs (VTRS)?

The current stock price of Viatris Ord Shs (VTRS) is $10.64 as of November 27, 2025.

What is the market cap of Viatris Ord Shs (VTRS)?

The market cap of Viatris Ord Shs (VTRS) is approximately 12.3B.
Viatris Inc Ord Shs

Nasdaq:VTRS

VTRS Rankings

VTRS Stock Data

12.25B
1.15B
0.28%
85.61%
3.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG